Genmab A/S (OTCMKTS:GNMSF) Short Interest Down 10.1% in October

Genmab A/S (OTCMKTS:GNMSF - Get Free Report) was the recipient of a significant decrease in short interest during the month of October. As of October 31st, there was short interest totalling 76,300 shares, a decrease of 10.1% from the October 15th total of 84,900 shares. Based on an average trading volume of 16,400 shares, the days-to-cover ratio is presently 4.7 days.

Genmab A/S Trading Down 0.9 %

Genmab A/S stock traded down $1.95 during mid-day trading on Monday, reaching $210.76. The company had a trading volume of 1,291 shares, compared to its average volume of 2,482. The business has a fifty day simple moving average of $236.51 and a 200 day simple moving average of $258.78. The company has a market cap of $13.78 billion, a P/E ratio of 20.45 and a beta of 1.07. Genmab A/S has a fifty-two week low of $202.30 and a fifty-two week high of $334.33.

Genmab A/S Company Profile

Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; and Amivantamab for advanced or metastatic gastric or esophageal cancer and NSCLC.